Nuheara IQBuds Max vs Otofonix Groove

The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.4/5 in our lab testing. At $499, it sits in the affordable tier of the OTC category, ranking #46 of 65 devices tested. The standout performance area for the IQBuds Max is music streaming, which scores a strong 4.3/5—significantly above the category average by 2.38 points. This makes it one of the better choices in the OTC space for users who prioritize audio entertainment alongside hearing assistance. However, speech performance presents a mixed picture: speech in quiet scores 2.0/5, falling 0.78 points below the category average, while speech in noise scores a low 1.5/5, though this is essentially at the category average. Own-voice comfort is mixed at 2.2/5, sitting slightly below the category average. Feedback handling scores a solid 3.4/5 in absolute terms, though this is 1.14 points below the category average of 4.54/5. The device features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The IQBuds Max is best suited for users who want an affordable entry into amplification with strong music streaming performance, but who have modest expectations for speech clarity improvement. Those prioritizing speech understanding may want to consider higher-ranked alternatives in the same price range, such as the Elehear Beyond or Apple AirPods Pro 2.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.